Aspirin-Exacerbated Respiratory Disease I: Advances in Basic Biology and Pathophysiologic Mechanisms
Friday, March 3, 2017: 7:00 AM-9:30 AM
Georgia World Congress Center, Building B, Level 2, Rooms B207-B208
2.50 CME/CE
Joshua A. Boyce , MD FAAAAI

Learning Objectives:
  1. Discuss the role of different sub-populations of innate lymphocytes in AERD
  2. Recognize the roles of receptors other than CysLT1 in the pathophysiology of AERD
  3. Explain the importance of prostaglandin E2 in protection from AERD
7:00 AM
Epigenetics of AERD and the Effect of High-Dose Aspirin: Potential Mechanisms of Treatment
Benjamin A. Raby, MD MPH
7:20 AM
Question & Answer
7:25 AM
Amplification of Th2 Immunopathology by Cysteinyl Leukotrienes in AERD
Nora A. Barrett, MD FAAAAI
7:45 AM
Question & Answer
7:50 AM
Control of Human Airway Function by Prostaglandins: Effectors and Protectors
Sven-Erik Dahlén, MD PhD
8:10 AM
Question & Answer
8:15 AM
The Spectrum of Nasal Polyp Lymphocyte Populations
Patrick J. Brennan, MD PhD
8:35 AM
Question & Answer
8:40 AM
TSLP as a Master Regulator of Nasal Polyposis and AERD
Atsushi Kato, PhD
9:00 AM
Question & Answer
9:05 AM
Mechanisms of Prostaglandin E2 Homeostasis and Dysregulation
Joshua A. Boyce, MD FAAAAI
9:25 AM
Question & Answer
See more of: Session